Cargando…
Development of a target identification approach using native mass spectrometry
A key step in the development of new pharmaceutical drugs is the identification of the molecular target and distinguishing this from all other gene products that respond indirectly to the drug. Target identification remains a crucial process and a current bottleneck for advancing hits through the di...
Autores principales: | Liu, Miaomiao, Van Voorhis, Wesley C., Quinn, Ronald J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840913/ https://www.ncbi.nlm.nih.gov/pubmed/33504855 http://dx.doi.org/10.1038/s41598-021-81859-4 |
Ejemplares similares
-
Native Mass Spectrometry for the Study of PROTAC GNE‐987‐Containing Ternary Complexes
por: Sternicki, Louise M., et al.
Publicado: (2021) -
Fragment-Based Screening of a Natural Product Library
against 62 Potential Malaria Drug Targets Employing Native Mass Spectrometry
por: Vu, Hoan, et al.
Publicado: (2018) -
Native Mass Spectrometry in Fragment-Based Drug Discovery
por: Pedro, Liliana, et al.
Publicado: (2016) -
Collision-Induced Affinity Selection Mass Spectrometry
for Identification of Ligands
por: Mak, Tin, et al.
Publicado: (2022) -
Identifying New Ligands for JNK3 by Fluorescence Thermal
Shift Assays and Native Mass Spectrometry
por: Cheng, Chongyun, et al.
Publicado: (2022)